Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01266174
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults
Conditions: Cognitive Impairment;   Schizophrenia
Interventions: Drug: Eltoprazine;   Drug: Placebo

Indicates status has not been verified in more than two years